share_log

Prelude Therapeutics | 8-K: Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update

SEC ·  May 8, 2023 08:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more